drugset / Trial / NCT07433387
Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals
Phase 1/2
Recruiting
30 enrolled
Shanxi Kangbao Biological Product Co., Ltd.
Institute of Pathogen Biology, Beijing, China · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
An Exploratory Multicenter, Open-label, Sequential Cohort Study to Evaluate the Preliminary Efficacy, Safety, and Pharmacokinetic Characteristics of LP-98 for Injection in Antiretroviral Therapy-Naive HIV-Infected Individuals
Timeline
- Start
- 2026-01-29
- Primary completion
- 2026-07-10
- Completion
- 2026-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LP-98 | Unknown | 20 mg | Subcutaneous |
| Subject | LP-98 | Unknown | 40 mg | Subcutaneous |
| Subject | LP-98 | Unknown | 80 mg | Subcutaneous |